Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
G. Fragoulis, Elena Nikiphorou, Jörg Larsen, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management
Suha Kadura, Ganesh Raghu
European Respiratory Review (2021) Vol. 30, Iss. 160, pp. 210011-210011
Open Access | Times Cited: 203
Drug-induced interstitial lung disease
Paolo Spagnolo, Philippe Bonniaud, Giulio Rossi, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 4, pp. 2102776-2102776
Closed Access | Times Cited: 71
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Giulia Cassone, Andreina Manfredi, Caterina Vacchi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1082-1082
Open Access | Times Cited: 95
Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease
Elizabeth F. Redente, Martin Aguilar, Bart P. Black, et al.
AJP Lung Cellular and Molecular Physiology (2018) Vol. 314, Iss. 6, pp. L998-L1009
Open Access | Times Cited: 77
Rheumatoid arthritis related interstitial lung disease – improving outcomes over 25 years: a large multicentre UK study
Clive Kelly, Mohamed Nisar, Suba Arthanari, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 4, pp. 1882-1890
Closed Access | Times Cited: 62
Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study
Else Helene Ibfelt, Rikke Kart Jacobsen, Tine Iskov Kopp, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 1, pp. 346-352
Closed Access | Times Cited: 61
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
Giulia Cassone, Andreina Manfredi, Fabiola Atzeni, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 277-277
Open Access | Times Cited: 56
Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
Antonella Laria, Alfredo Maria Lurati, Gaetano Zizzo, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
Mrinalini Dey, György M. Nagy, Elena Nikiphorou
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1773-1779
Open Access | Times Cited: 31
Phosphorus dendron nanomicelles as a platform for combination anti-inflammatory and antioxidative therapy of acute lung injury
Jin Li, Liang Chen, Changsheng Li, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3407-3419
Open Access | Times Cited: 29
Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020
Katinka Albrecht, Anja Strangfeld, Ursula Marschall, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002777-e002777
Open Access | Times Cited: 16
Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape
Mir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 5, pp. 1108-1118
Open Access | Times Cited: 40
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
Yukai Wang, Shaoqi Chen, Shaoyu Zheng, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
Hideaki Yamakawa, Takashi Ogura, Hideto Kameda, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3806-3806
Open Access | Times Cited: 35
Clinical features of rheumatoid arthritis
Matthew Colquhoun, Malvika Gulati, Ziad Farah, et al.
Medicine (2022) Vol. 50, Iss. 3, pp. 138-142
Closed Access | Times Cited: 23
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
Ayodeji Adegunsoye, Rachel Baccile, Thomas J. Best, et al.
The Lancet Regional Health - Americas (2023) Vol. 25, pp. 100566-100566
Open Access | Times Cited: 12
Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system
Kenji Onda, Takeshi Honma, Koichi Masuyama
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 11
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis
Tsutomu TOGASHI, Ryuhei Ishihara, Ryu Watanabe, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1529-1529
Open Access
Systematic Pharmacovigilance Analysis for Medications Associated with Organizing Pneumonia
Peng Tang, Yongli Zhao, Xianghua Yi
(2025)
Closed Access
Huangqi Guizhi Wuwu Decoction Improves Arthritis and Pathological Damage of Heart and Lung in TNF-Tg Mice
Yi Wang, Tao Chen, Can Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease
Paola Triggianese, Paola Conigliaro, Erica De Martino, et al.
Open Access Rheumatology Research and Reviews (2023) Vol. Volume 15, pp. 65-79
Open Access | Times Cited: 10
Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development
Eun Ji Jeong, Hyun‐Seok Hong, Yeon‐Ah Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2682-2682
Open Access | Times Cited: 3
Methotrexate Use and Risk of Interstitial Lung Disease in Dermatomyositis
Jill Shah, William Mark Richardson, Lavanya Mittal, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 6, pp. 676-676
Closed Access | Times Cited: 3
Lung inflammation in the pathogenesis of rheumatoid arthritis
M. Kristen Demoruelle, Timothy M. Wilson, Kevin D. Deane
Immunological Reviews (2020) Vol. 294, Iss. 1, pp. 124-132
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top